Skip to search.
 TSX Up 0.94% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On LOR.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Lorus Therapeutics, Inc. (LOR.TO)

-Toronto
0.50 0.00(0.00%) 3:24PM EDT
Add to Portfolio
Prev Close:0.50
Open:0.50
Bid:0.50
Ask:0.51
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.50 - 0.52
52wk Range:0.17 - 1.04
Volume:206,455
Avg Vol (3m):458,252
Market Cap:21.15M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (May-14) :-0.14
Quarterly EPS Est (May-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lorus Therapeutics Inc., a biopharmaceutical company, engages in the discovery, research, and development of novel anticancer therapies in Canada. Its product pipeline includes LOR-253, an anticancer agent for the treatment of human cancers, inclu... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback